The purpose of the study was to investigate the expression of Aurora-A in human
laryngeal squamous cell carcinoma (LSCC) and to explore the effects of Aurora-A silencing on invasion and
chromosomal instability in
laryngeal cancer HEp-2 cells. The expression of Aurora-A
mRNA and
protein were studied using reverse transcription-PCR and Western blot in LSCC tissues and corresponding normal epithelium, respectively. In addition, the correlation between Aurora-A expression and clinicopathologic characteristics was analyzed in LSCC patients. Furthermore, HEp-2 cells were transfected with Aurora-A
short hairpin RNA and the effects of knockdown of Aurora-A on
tumor invasion and
chromosomal instability were investigated. The results showed that expression of Aurora-A
mRNA was significantly upregulated in laryngeal
tumor tissue compared with that in normal tissue (P = 0.001), and overexpression of Aurora-A was found in 64.0% (16 of 25) of the patients by Western blotting. Upregulation of Aurora-A
mRNA was significantly correlated with regional
lymph node metastasis (P = 0.007) and clinical stage III/IV (P = 0.022). Overexpression of Aurora-A was significantly associated with
lymph node metastasis (P = 0.027). Furthermore, disruption of Aurora-A using RNA interference technique suppressed invasive ability and
chromosomal instability in HEp-2 cells. In conclusion, Aurora-A expression is elevated in human LSCC and associated with regional
lymph node metastasis and late clinical stage. Overexpression of Aurora-A may contribute to LSCC
carcinogenesis and progression partially due to enhancement of invasion ability and
chromosomal instability.